The Diagnosis and Management of Vasovagal Syncope in Pediatric Patients
DOI:
https://doi.org/10.12974/2309-6179.2022.07.01Keywords:
Diagnosis, Management, Vasovagal syncope, Pediatric patientsAbstract
Vasovagal syncope is the most common cause of syncope in pediatric patients. The present study is aim to provide a comprehensive literature review of the latest advances in the diagnosis and treatment of vasovagal syncope in children. Diagnosis of vasovagal syncope is based on clinical history. For patients with suspected VVS but lack of confident diagnosis after initial assessment, head-up tilt test is helpful. There are four options for treatment of vasovagal syncope: conservative therapy, pharmacologic therapy, pacemaker therapy, and catheter ablation of ganglionated plexi. Conservative therapy (health education, avoidance of triggers, salts and water intake, physical countermeasures and orthostatic training) is recommended for patients with occasional syncope. Pharmacological therapy should be considered for patients with recurrent syncope or for whom conservative therapy has failed. Patients with the predominantly cardioinhibitory response, associated with repeated injury, limited prodromes, and documented asystole may benefit from cardiac pacing. Catheter ablation of ganglionated plexi is a new strategy, its efficacy and safety in pediatric patients should be verified by randomized controlled trials.
References
da Silva RM. Syncope: epidemiology, etiology, and prognosis. Front Physiol, 2014; 5: 471. http//:dx.doi.org/10.3389/fphys.2014.00471
Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH. Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev, 2008; 16(1): 4-20. http//:dx.doi.org/10.1097/CRD.0b013e31815c8032
Wang C, Li Y, Liao Y, Tian H, Huang M, Dong X, et al. 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents. Sci Bull, 2018; 63(23): 1558-1564. http//:dx.doi.org/10.1016/j.scib.2018.09.019
Tao CY, Jin HF, Du JB. Management of orthostatic intolerance in children: the state of the art. World J Pediatr, 2020; 16(6): 543-548. http//:dx.doi.org/10.1007/s12519-019-00329-0
Liao Y, Du J. Pathophysiology and individualized management of vasovagal syncope and postural tachycardia syndrome in children and adolescents: an update. Neurosci Bull, 2020; 36(6): 667-681. http//:dx.doi.org/10.1007/s12264-020-00497-4
Chu W, Wang C, Lin P, Li F, Wu L, Xie Z. Transient aphasia: a rare complication of head-up tilt test. Neurol Sci, 2014; 35(7): 1127-32. http//:dx.doi.org/10.1007/s00246-015-1097-5
Cai H, Wang S, Zou R, Liu P, Yang H, Wang Y, et al. Symptoms score: a new instrument to assess orthostatic intolerance in children and adolescents. J Child Neurol, 2020; 35(12): 835-843. http//:dx.doi.org/10.1177/0883073820936025
Sanatani S, Chau V, Fournier A, Dixon A, Blondin R, Sheldon RS. Canadian Cardiovascular Society and Canadian Pediatric Cardiology Association Position Statement on the Approach to Syncope in the Pediatric Patient. Can J Cardiol, 2017; 33(2): 189-198. http//:dx.doi.org/10.1016/j.cjca.2016.09.006
Klein KM, Berkovic SF. Genetics of vasovagal syncope. Auton Neurosci, 2014; 184: 60-65. http//:dx.doi.org/10.1016/j.autneu.2014.03.008
Azevedo MC, Barbisan JN, Silva EO. Neurocardiogenic syncope and hereditarity. Rev Assoc Med Bras (1992), 2009; 55(1): 19-21. http//:dx.doi.org/10.1590/s0104-42302009000100009
Zhang W, Wang S, Wang C, Liu L, Lin P, Li F, et al. Head-up tilt test results in child twins with nervous mediated syncope. Int J Cardiol, 2016; 221: 194-197. http//:dx.doi.org/10.1016/j.ijcard.2016.07.023
Hernandez-Pacheco G, Gonzalez-Hermosillo A, Murata C, Yescas P, Espinola-Zavaleta N, Martinez M, et al. Arg347Cys polymorphism of alpha1a-adrenergic receptor in vasovagal syncope. Case-control study in a Mexican population. Auton Neurosci, 2014,183:66-71. http//:dx.doi.org/10.1016/j.autneu.2014.01.005
Hernandez-Pacheco G, Serrano H, Marquez MF, Hermosillo AG, Perez-Vielma N, Sotomayor A, et al. Genetic study of the vasovagal syncope associated to the Arg389Gly polymorphism of the beta1 adrenergic receptor. Arch Cardiol Mex, 2008; 78(2): 134-138.
Saadjian AY, Gerolami V, Giorgi R, Mercier L, Berge-Lefranc JL, Paganelli F, et al. Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. Eur Heart J, 2009; 30(12): 510-515. http//:dx.doi.org/10.1093/eurheartj/ehp126
Lelonek M, Pietrucha T, Matyjaszczyk M, Goch JH. Mutation T/C, Ile 131 of the gene encoding the alfa subunit of the human Gs protein and predisposition to vasovagal syncope. Circ J, 2008; 72(4): 558-562. http//:dx.doi.org/10.1253/circj.72.558
Holmegard HN, Benn M, Mehlsen J, Haunso S. Genetic variation in the parasympathetic signaling pathway in patients with reflex syncope. Genet Mol Res, 2013; 12(3): 2601-2610. http//:dx.doi.org/10.4238/2013.January.30.6
Zou R, Wang S, Li F, Lin P, Zhang J, Wang Y, et al. The application of head-up tilt test to diagnose hemodynamic type of orthostatic intolerance in children aged between 3 to 5 years old. Front Pediatr 2021; 9: 623880. http//:dx.doi.org/10.3389/fped.2021.623880
Chen L, Wang C, Wang H, Tian H, Tang C, Jin H, et al. Underlying diseases in syncope of children in China. Med Sci Monit, 2011; 17(6): PH49-53. http//:dx.doi.org/10.12659/msm.881795
Zhang Q, Jin H, Qi J, Yan H, Du J. Diagnostic value of serum brain natriuretic peptide in syncope in children and adolescents. Acta Paediatr, 2013; 102(5): e210-e214. http//:dx.doi.org/10.1111/apa.12182
Zhao J, Han Z, Zhang X, Du S, Liu AD, Holmberg L, et al. A cross-sectional study on upright heart rate and BP changing characteristics: basic data for establishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension. BMJ Open, 2015; 5(6): e007356. http//:dx.doi.org/10.1136/bmjopen-2014-007356
Cai H, Wang S, Zou R, Li F, Zhang J, Wang Y, et al. Diagnostic value of diurnal variability of orthostatic heart rate increment in children and adolescents with POTS. Front Pediatr, 2021; 9: 644461. http//:dx.doi.org/10.3389/fped.2021.644461
Zhang F, Li X, Stella C, Chen L, Liao Y, Tian C, et al. Plasma hydrogen sulfide in differential diagnosis between vasovagal syncope and postural orthostatic tachycardia syndrome in children. J Pediatr, 2012; 160(2): 227-231. http//:dx.doi.org/10.1016/j.jpeds.2011.08.008
Zaidi A, Clough P, Cooper P, Scheepers B, Fitzpatrick AP. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol, 2000; 36(1): 181- 184. http//:dx.doi.org/10.1016/s0735-1097(00)00700-2
Zou R, Wang S, Zhu L, Wu L, Lin P, Li F, et al. Calgary score and modified Calgary score in the differential diagnosis between neurally mediated syncope and epilepsy in children. Neurol Sci, 2017; 38(1): 143-149. http//:dx.doi.org/10.1007/s10072-016-2740-5
Romme JJ, Reitsma JB, Go-Schon IK, Harms MP, Ruiter JH, Luitse JS, et al. Prospective evaluation of non- pharmacological treatment in vasovagal syncope. Europace, 2010; 12(4): 567-573. http//:dx.doi.org/10.1093/europace/eup414
Zeng H, Ge K, Zhang W, Wang G, Guo L. The effect of orthostatic training in the prevention of vasovagal syncope and its influencing factors. Int Heart J, 2008; 49(6): 707- 712. http//:dx.doi.org/10.1093/europace/eup414
Tao C, Li X, Tang C, Jin H, Du J. Acceleration index predicts efficacy of orthostatic training on vasovagal syncope in children. J Pediatr, 2019; 207: 54-58. http//:dx.doi.org/10.1016/j.jpeds.2018.10.063
Chu W, Wang C, Wu L, Lin P, Li F, Zou R. Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope. Pediatr Cardiol, 2015; 36(4): 867-872. http//:dx.doi.org/10.1007/s00246-015-1097-5
Li W, Wang S, Liu X, Zou R, Tan C, Wang C. Assessment of efficacy of oral rehydration salts in children with neurally mediated syncope of different hemodynamic patterns. J Child Neurol, 2019; 34(1): 5-10. http//:dx.doi.org/10.1177/0883073818803035
Wen C, Wang S, Zou R, Wang Y, Tan C, Xu Y, et al. Duration of treatment with oral rehydration salts for vasovagal syncope in children and adolescents. Turk J Pediatr, 2020; 62(5): 820-825. http//:dx.doi.org/10.24953/turkjped.2020.05.014
Jarjour IT, Jarjour LK. Low iron storage in children and adolescents with neurally mediated syncope. J Pediatr, 2008; 153(1): 40-44. http//:dx.doi.org/10.1016/j.jpeds.2008.01.034
Guven B, Oner T, Tavli V, Yilmazer MM, Demirpence S, Mese T. Low iron storage in children with tilt positive neurally mediated syncope. World J Pediatr, 2013; 9(2): 146-151. http//:dx.doi.org/10.1007/s12519-012-0396-7
Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, et al. Effect of metoprolol on quality of life in the prevention of syncope trial. J Cardiovasc Electrophysiol, 2009; 20(10): 1083-1088. http//:dx.doi.org/10.1111/j.1540-8167.2009.01518.x
Liao Y, Li X, Zhang Y, Chen S, Tang C, Du J. alphaAdrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data. Acta Paediatr, 2009; 98(7): 1194-1200. http//:dx.doi.org/10.1111/j.1651-2227.2009.01289.x
Qingyou Z, Junbao D, Chaoshu T. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr, 2006; 149(6): 777-780. http//:dx.doi.org/10.1016/j.jpeds.2006.07.031
Chen L, Du JB, Zhang QY, Wang C, Du ZD, Wang HW, et al. A multicenter study on treatment of autonomous nerve- mediated syncope in children w ith beta-receptor blocker. Chin J Pediatr, 2007; 45(12): 885-888.
Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation, 2006; 113(9): 1164-1170. http//:dx.doi.org/10.1161/CIRCULATIONAHA.105.535161
Tao C, Xu B, Liao Y, Li X, Jin H, Du J. Predictor of syncopal recurrence in children with vasovagal syncope treated with metoprolol. Front Pediatr, 2022; 10: 870939. http//:dx.doi.org/10.3389/fped.2022.870939
Yuan P, Li X, Tao C, Du X, Zhang C, Du J, et al. Poincaré plot can be a useful tool to select potential responders to metoprolol therapy in children with vasovagal syncope. Int J Gen Med, 2022; 15: 2681-2693. http//:dx.doi.org/10.2147/IJGM.S352928
Scott WA, Pongiglione G, Bromberg BI, Schaffer MS, Deal BJ, Fish FA, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol, 1995; 76(5): 400-402. http//:dx.doi.org/10.1016/s0002-9149(99)80110-6
Sheldon R, Raj SR, Rose MS, Morillo CA, Krahn AD, Medina E, et al. Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial. J Am Coll Cardiol, 2016; 68(1): 1-9. http//:dx.doi.org/10.1016/j.jacc.2016.04.030
Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double- blind, placebo-controlled, randomized trial. J Am Coll Cardiol, 2005; 45(4): 484-488. http//:dx.doi.org/10.1016/j.jacc.2004.11.033
Flevari P, Leftheriotis D, Repasos E, Katsaras D, Katsimardos A, Lekakis J. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity. Europace, 2017; 19(1): 127-131. http//:dx.doi.org/10.1093/europace/euw153
Sheldon RS, Ritchie D, McRae M, Raj S. Norepinephrine transport inhibition for treatment of vasovagal syncope. J Cardiovasc Electrophysiol, 2013; 24(7): 799-803. http//:dx.doi.org/10.1111/jce.12111
McLeod KA, Wilson N, Hew itt J, Norrie J, Stephenson JB. Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures. Heart, 1999; 82(6): 721725. http//:dx.doi.org/10.1136/hrt.82.6.721
Paech C, Wagner F, Mensch S, Antonin Gebauer R. Cardiac pacing in cardioinhibitory syncope in children. Congenit Heart Dis, 2018; 13(6): 1064-1068. http//:dx.doi.org/10.1111/chd.1268
Sun W, Zheng L, Qiao Y, Shi R, Hou B, Wu L, et al. Catheter ablation as a treatment for vasovagal syncope: long-term outcome of endocardial autonomic modification of the left atrium. J Am Heart Assoc, 2016; 5(7): e003471. http//:dx.doi.org/10.1161/JAHA.116.003471
Lu Y, Wei W, Upadhyay GA, Tung R. Catheter-based cardioneural ablation for refractory vasovagal syncope: first U.S. report. JACC Case Rep, 2020; 2(8): 1161-1165. http//:dx.doi.org/10.1016/j.jaccas
